Author Archives: Guest Blogger

New Scottish Medicines Fund Boosted by UK PPRS

 The 2014 Pharmaceutical Price Regulation Scheme (PPRS), the voluntary agreement to cover pricing of branded medicines supplied to the NHS in the UK, included provisions for member companies to pay back to the Department of Health (DH) if spend went over pre-agreed growth rates.  That has translated into £150 million already for the first two […]
Posted in Europe | Tagged , , , , | Leave a comment

Is Pfizer Ready for Another Acquisition?

After Pfizer’s aborted acquisition of AstraZeneca, will the drug maker likely approach another company for takeover? This Applied Clinical Trials article discusses some background on Pfizer’s financial history, evaluates its R&D portfolio, and determines whether it is ready for another acquisition attempt. Read more…
Posted in Deals, Strategy | Tagged , , | Leave a comment

The Shrinking CMO Industry

By Jim Miller. Exits from the CMO industry are a more recent development that seems to be picking up momentum. Examples of CMOs leaving the industry in the past year include the contract manufacturing units of Bayer and Boehringer-Ingelheim; Pharmalucence; and SCM Pharma. There have been two principal drivers of these developments: growing demand for […]
Posted in Guest Blog, Manufacturing, Strategy | Tagged , | Leave a comment

Preparing for Reentry: A Physician’s Story

By Daniel Laury, M.D. You would expect that, given a physician shortage, my goal of getting back into obstetrics would be supported and even welcomed.  The Association of American Medical Colleges expects that the US will have over 91,000 too few physicians by 2020.  I graduated medical school in 1988, completed an OBG residency in […]
Posted in Guest Blog, healthcare | Tagged , , | 1 Comment
  • Categories

  • Meta